A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells

Cytotherapy

Volumn 10, Issue 4, 2008, Pages 364-375

  Rizzo, R ^a   Campioni, D ^b   Stignani, M ^a   Melchiorri, L ^a   Bagnara, G P ^c   Bonsi, L ^c   Alviano, F ^c   Lanzoni, G ^c   Moretti, S ^b   Cuneo, A ^b   Lanza, F ^b   Baricordi, O R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

HLA G; Immunoregulation; Interleukin 10; Lymphoproliferation; Mesenchymal stromal cells

Indexed keywords

HLA G ANTIGEN; INTERLEUKIN 10; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ;

ADULT; ANTIGEN DETECTION; ANTIGEN FUNCTION; ARTICLE; CELL AGING; CELL CULTURE; CELL SECRETION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STROMAL CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STROMA CELL;

EID: 47249127693     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802105299     Document Type: Article

References (64)

1. Uccelli, A., Pistoia, V. and Moretta, L. (2007) Mesenchymal stem cells: a new strategy for immunosuppression?. Trends Immunol, 28, pp. 219-226.
2. Stagg, J. (2007) Immune regulation by mesenchymal stem cells: Two sides to the coin. Tissue Antigens, 69, pp. 1-9.
3. Tyndall, A. and Saccardi, R. (2005) Haematopoietic stem cell transplantation in the treatment of the severe autoimmune disease results from phase I/II study, prospective randomized trials and future directions. Clin Exp Immunol, 141, pp. 1-9.
4. Le Blanc, K, Tammik, C. Rosendahl, K. et al. (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal cells. Exp Hematol, 31, pp. 890-896.
5. Rasmusson, I., Ringden, O., Sundberg, B. and Le Blanc, K. (2005) Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res, 305, pp. 33-41.
6. Di Nicola, M, Carlo-Stella, C. Magni, M. et al. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non specific mitogenic stimuli. Blood, 99, pp. 3838-3843.
7. Bocelli-Tyndall, C., Bracci, L. Spagnoli, G. et al. (2007) Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology, 46, pp. 403-408.
8. + regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica, 92, pp. 872-877.
9. + T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica, 90, pp. 516-525.
10. Klyushnenkova, E., Mosca, JD Zernetkina, MK et al. (2005) T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance and suppression. J Biomed Sci, 12, pp. 45-57.
11. Beyth, S., Borovsky, Z. Mevorach, D. et al. (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105, pp. 2214-2219.
12. Sakaguchi, S., Sakaguchi, N. Asano, M. et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2R receptor alpha chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 155, pp. 1151-1164.
13. Yue, FY, Dummer, R. Geertsen, R. et al. (1997) Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer, 71, pp. 630-637.
14. + T cell response. J Immunol, 178, pp. 5429-5433.
15. Moreau, P., Adrian-Cabestre, F. Menier, C. et al. (1999) IL-10 selectively induces HLA-G expression in human throphoblasts and monocytes. Int Immunol, 11, pp. 803-811.
16. Carosella, ED, Paul, P., Moreau, P. and Rouas-Freiss, N. (2000) HLA-G and HLA-E: Fundamental and pathophysiological aspects. Immunol Today, 21, pp. 532-534.
17. Hviid, TV. (2006) HLA-G in human reproduction: Aspects of genetics, function and pregnancy complications. Hum Reprod Update, 12, pp. 209-232.
18. Fujii, T., Ishitani, A. and Geraghty, DE. (1994) A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol, 153, pp. 5516-5524.
19. Aractingi, S., Briand, N. Le Danff, C et al. (2001) HLA-G and NK receptor are expressed in psoriatic skin: A possible pathway for regulating infiltrating T cells?. Am J Pathol, 159, pp. 71-77.
20. Fainardi, E., Rizzo, R. Melchiorri, L. et al. (2006) Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult Scler, 12, pp. 2-12.
21. Wiendl, H., Feger, U. Mittelbronn, M. et al. (2005) Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: Implications for CNS immunity. Brain, 128, pp. 2689-2704.
22. Derrien, M., Pizzato, N. Dolcini, G. et al. (2004) Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1. J Gen Virol, 85, pp. 1945-1954.
23. Matte, C., Lajoie, J. Lacaille, J. et al. (2004) Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS, 18, pp. 427-431.
24. Rouas-Freiss, N., Moreau, P., Menier, C. and Carosella, ED. (2003) HLA-G in cancer: A way to turn off the immune system. Semin Cancer Biol, 13, pp. 325-336.
25. Rouas-Freiss, N., Moreau, P., Ferrone, S. and Carosella, ED. (2005) HLA-G proteins in cancer: Do they provide tumor cells with an escape mechanism?. Cancer Res, 65, pp. 10139-10144.
26. Lila, N., Carpentier, A. Amrein, C. et al. (2000) Implication of HLA-G molecules in hearth-graft acceptance. Lancet, 355, p. 2138.
27. Qiu, J., Terasaki, PI Miller, J. et al. (2006) Soluble HLA-G expression and renal graft acceptance. Am J Transplant, 6, pp. 2152-2156.
28. Rouas-Freiss, N., Goncalves, RM Menier, C. et al. (1997) Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA, 94, pp. 11520-11525.
29. Riteau, B., Rouass-Freiss, N. Menier, C. et al. (2001) HLA-G2, -G3 and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol, 166, pp. 5018-5026.
30. Le Gal, FA, Riteau, B. Sedlik, C. et al. (1999) HLA-G mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol, 11, pp. 1351-1356.
31. + cells by interacting with CD8. J Immunol, 164, pp. 6100-6104.
32. Bainbridge, DR, Ellis, SA and Sargent, IL. (2000) HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol, 48, pp. 17-26.
33. + T cell regulatory mechanism. Proc Natl Acad Sci USA, 98, pp. 12150-12155.
34. Le Rond, S, Azema, C. Krawice-Radanne et al. (2006) Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol, 176, pp. 3266-3276.
35. Horuzsko, A., Lenfant, F., Munn, DH and Mellor, AL. (2001) Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol, 13, pp. 385-394.
36. Ristich, V., Liang, S. Zhang, W. et al. (2005) Tolerization of dendritic cells by HLA-G. Eur J Immunol, 35, pp. 1133-1142.
37. Le Blanc, K and Ringden, O. (2005) Immunobiology of human mesenchymal stem cells and future use in hemopoietic stem cell transplantation. Biol Blood Marrow Transplant, 11, pp. 321-334.
38. Ringden, O., Uzunel, M. Rasmusson, I. et al. (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 81, pp. 1390-1397.
39. De Coppi, P., Bartsch Jr, G. Siddiqui, MM et al. (2007) Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol, 25, pp. 100-106.
40. Alviano, F., Fossati, V. Marchionni, C. et al. (2007) Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol, 7, p. 11.
41. Pasquinelli, G., Tazzari, PL Vaselli, C. et al. (2007) Thoracic aortas from multi-organ donors are suitable for obtaining resident angiogenic mesenchymal stromal cells. Stem Cells, 25, pp. 1627-1634.
42. Zuk, PA, Zhu, M. Ashjian, P. et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell, 13, pp. 4279-4295.
43. Pierdomenico, L., Bonsi, L. Calvitti, M. et al. (2005) Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation, 80, pp. 836-842.
44. Lanza, F., Campioni, D. Moretti, S. et al. (2007) Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders. Leukemia, 21, pp. 378-381.
45. Rizzo, R., Mapp, CE Melchiorri, L. et al. (2005) Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma. J Allergy Clin Immunol, 115, pp. 508-513.
46. Rebmann, V., Lemaoult, J. Rouas-Freiss, N. et al. (2004) Report of the wet workshop for quantification of soluble HLA-G in Essen. Hum Immunol, 66, pp. 853-863.
47. Rizzo, R., Fuzzi, B. Stignani, M. et al. (2007) Soluble HLA-G molecules in follicular fluid: A tool for oocyte selection in IVF?. J Reprod Immunol, 74, pp. 133-142.
48. Sotiropoulou, P., Perez, SA Gritzapis, AD et al. (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells, 24, pp. 74-85.
49. Mello, M. and Tuan, RS. (2006) Effects of TGF-beta1 and triiodothyronine on cartilage maturation: In vitro analysis using long-term high-density micromass cultures of chick embryonic limb mesenchymal cells. J Orthop Res, 24, pp. 2095-2105.
50. Theill, LE, Boyle, WJ and Penninger, JM. (2002) RANK-L and RANK: T cells, bone loss, and mammalian evolution. Ann Rev Immunol, 20, pp. 795-823.
51. Meisel, R., Zibert, A. Laryea, M. et al. (2004) Human bone marrow stromal cells inhibit allogeneic T-cell response by indoleamine 2,3-dioxigenase-mediated tryptophan-degradation. Blood, 103, pp. 4619-4621.
52. Zidi, I., Guillard, C. Marcou, C. et al. (2006) Increase in HLA-G1 proteolytic shedding by tumor cells: A regulatory pathway controlled by NF-kappaB inducers. Cell Mol Life Sci, 63, pp. 2669-2681.
53. Lopez, AS, Alegre, E. LeMaoult, J. et al. (2006) Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells. Mol Immunol, 43, pp. 2151-2160.
54. Rebmann, V., Busemann, A., Lindemann, M. and Grosse-Wilde, H. (2003) Detection of HLA-G5 secreting cells. Hum Immunol, 11, pp. 1017-1024.
55. Groh, ME, Maitra, B., Szekely, E. and Koc, ON. (2005) Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol, 33, pp. 928-934.
56. Weston, LE, Geczy, AF and Briscoe, H. (2006) Production of IL-10 by alloreactive sibling donor cell and its influence in the development of acute GHVD. Bone Marrow Transplant, 37, pp. 207-212.
57. Min, CK, Kim, GB Park, G. et al. (2007) IL-10 transduced bone marrow mesenchimal stem cells can attenuate the severity of acute graft-versus-host diseases after experimental allogeneic stem cells transplantation. Bone Marrow Transplant, 39, pp. 637-645.
58. Crisostomo, PR, Wang, M. Wairiuko, GM et al. (2006) High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock, 26, pp. 575-580.
59. Mitsdoerffer, M., Schreiner, B. Kieseier, BC et al. (2005) Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: Rationale for the therapy of multiple sclerosis. J Neuroimmunol, 159, pp. 155-164.
60. Naji, A., Durrbach, A., Carosella, ED and Rouas-Freiss, N. (2007) Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/IL-T4/FasL-mediated pathways. Hum Immunol, 68, pp. 233-239.
61. Feger, U., Tolosa, E. Huang, YH et al. (2007) HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation. Blood, 110, pp. 568-577.
62. Gotherstrom, C., West, A. Liden, J. et al. (2005) Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica, 90, pp. 1017-1026.
63. Nasef, A., Mathieu, N. Chapel, A. et al. (2007) Immunosuppressive effects of mesenchymal stem cells: Involvement of HLA-G. Transplantation, 84, pp. 231-237.
64. Selmani, Z., Naji, A. Zidi, I. et al. (2008) HLA-G5 secretion by human mesenchymal stem cells is required to suppress T-lymphocyte and NK function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells, 26, pp. 212-222.